Xaio-Lian Zhang | Immunology | Best Researcher Award

Published on by Academic Awards

Prof. Xaio-Lian Zhang | Immunology | Best Researcher Award

Prof. Xaio-Lian Zhang at Wuhan University, China

Dr. Xiao-Lian Zhang 🎓 is the Hongyi and Luojia Distinguished Professor and Chair of Immunology at Wuhan University 🧬. A leading expert in infection, glyco-immunity, and vaccine development 💉, she focuses on immune evasion by Mycobacterium tuberculosis and Hepatitis C/B viruses 🦠. With a PhD from HKUST and postdoc at the University of Maryland , she has published 190+ papers in top journals 📚 and holds 46 patents 🧪. A recipient of China’s Outstanding Young Scientist Fund 🌟, her innovative research in intracellular pathogens and glycan-targeted therapies has been globally recognized and ranked in the top 2% by Faculty of 1000 🌍.

Publication Profile📚

Orcid

Academic Background🎓

Dr. Xiao-Lian Zhang 🎓 earned her PhD in Biochemistry from the Hong Kong University of Science and Technology (1993–1997) and completed her postdoctoral training at the University of Maryland, USA  (1997–2001). She is currently the Hongyi and Luojia Distinguished Professor and Chair of Immunology at Wuhan University 🧬. Her research focuses on infection, glyco-immunity, and vaccine development 💉, especially against Mycobacterium tuberculosis and Hepatitis B/C viruses 🦠. With over 190 publications 📚, 46 patents 🧪, and numerous national awards 🌟, her work ranks in the top 2% globally 🌍 for its impact and innovation.

Professional background💼

Dr. Xiao-Lian Zhang 💼 is a Hongyi and Luojia Distinguished Professor at Wuhan University and serves as the Chair of the Immunology Department 🧬. She also leads the Hubei Provincial Key Laboratory of Allergic and Immune-related Diseases 🔬. Her research expertise includes infection, glyco-immunity, immune evasion, and vaccine development 💉, particularly targeting Mycobacterium tuberculosis and Hepatitis B/C viruses 🦠. She has led major national programs such as the 973 Program and received the National Outstanding Young Scientist Fund 🌟. With over 190 top-tier publications 📚 and 46 granted patents 🧪, she is recognized globally 🌍 for scientific excellence.

Awards and Honors🏅

Dr. Xiao-Lian Zhang 🏅 has received numerous prestigious awards for her outstanding contributions to biomedical research 🌟. She is a recipient of the National Outstanding Young Scientist Fund 🧬 and was selected for China’s “New Century” National Talent Program . As a Hongyi and Luojia Distinguished Professor, she also leads national-level research projects including the 973 Program and Major Infectious Disease Initiatives 🧪. Her innovative work in infection and glyco-immunity has earned over 190 publications 📚 and global recognition, ranking her among the top 2% of scientists worldwide 🌍 according to Faculty of 1000 🏆.

Research Focus🔬

Dr. Xiao-Lian Zhang 🔬 is a leading researcher in infection and immunity, with a special focus on intracellular pathogens like Mycobacterium tuberculosis and Hepatitis B/C viruses 🦠. Her groundbreaking work explores glyco-immunity, immune evasion mechanisms, and the development of glycan-targeted vaccines, drugs, and diagnostics 💉🧪. She has pioneered novel approaches in immunotherapy and molecular diagnostics, enhancing both understanding and treatment of infectious diseases 🧬. Her research has been published in prestigious journals 📚 and frequently cited in leading reviews, earning her recognition among the top 2% of global scientists 🌍 for impactful, innovative scientific contributions.

Publication Top Notes🌟

🔬 Mycobacterial EST12 activates a RACK1-NLRP3-gasdermin D pyroptosis-IL-1β immune pathway
Year: 2020 | Published in: Science Advances

🧬 Binding of cellular nucleolin with the viral core RNA G-quadruplex structure suppresses HCV replication
Year: 2019 | Published in: Nucleic Acids Research

🧪 Detection of circulating Mycobacterium tuberculosis specific DNA by droplet digital PCR for vaccine evaluation
Year: 2018 | Published in: Emerging Microbes & Infections

💉 A Single ssDNA Aptamer Binding to Mannose-Capped Lipoarabinomannan Enhances Immunoprotection against TB
Year: 2016 | Published in: JACS

🧫 Knockdown of Mgat5 Inhibits Breast Cancer Cell Growth with Activation of CD4⁺ T Cells and Macrophages
Year: 2015 | Published in: Journal of Immunology

🧬 Aptamer against mannose-capped lipoarabinomannan inhibits Mycobacterium tuberculosis in mice and monkeys
Year: 2014 | Published in: Molecular Therapy

🧪 CFP10 and ESAT6 aptamers as effective Mycobacterial antigen diagnostic reagents
Year: 2014 | Published in: Journal of Infection

🧬 Ficolin-2 inhibits HCV infection, Apolipoprotein E3 mediates viral immune escape
Year: 2014 | Published in: Journal of Immunology

Conclusion

Professor Xiao-Lian Zhang is a globally recognized leader in infection biology, immunology, and vaccine research 🧬🦠. With a PhD from HKUST and postdoctoral training at the University of Maryland , she currently holds prestigious positions as Hongyi and Luojia Distinguished Professor and Chair of Immunology at Wuhan University 💼. Her research on glyco-immunity, intracellular pathogens like Mycobacterium tuberculosis and Hepatitis B/C viruses, and glycan-targeted therapies has led to 190+ high-impact publications 📚 and 46 granted patents 🧪. Widely cited and ranked in the top 2% globally 🌍, she has secured major national grants and made transformative contributions to science, making her a highly deserving candidate for the Best Researcher Award 🏆.

Jaime Rosa Duque | Immunology | Best Researcher Award

Published on by Academic Awards

Dr. Jaime Rosa Duque | Immunology | Best Researcher Award

Dr. Jaime Rosa Duque, The University of Hong Kong, Hong Kong

Dr. Jaime Sou Da Rosa Duque, MD, PhD, is a Clinical Assistant Professor at the University of Hong Kong specializing in paediatric immunology, allergy, and infectious diseases. He holds multiple board certifications and has completed fellowships at Stanford University. With extensive experience in paediatrics, he has contributed significantly to allergy research and immunology. His dedication to advancing child health has earned him honorary appointments and numerous awards, making him a distinguished leader in his field. 🌍🏅

Publication Profile

Orcid

🎓 Education

Dr. Duque earned his MD with Distinction in Research from the University of California, Irvine, and a PhD in Pharmacology and Toxicology. He holds a BS in Biochemistry from UCLA with Latin honors. His postgraduate training includes paediatrics at Children’s Hospital Los Angeles, followed by a prestigious fellowship in Allergy and Immunology at Stanford University. Additionally, he obtained a Diploma of Child Health from the UK. 📘👨‍🎓

Experience

Dr. Duque is a Clinical Assistant Professor at the University of Hong Kong and an Honorary Distinguished Professor at Guangzhou Medical University. His experience includes leadership roles at Hong Kong Children’s Hospital and Queen Mary Hospital. Previously, he served as a fellow at Stanford University, contributing to groundbreaking research in allergy and immunology. He has extensive experience in paediatric clinical care, academic mentorship, and collaborative research. 🏥📚

🏆 Awards and Honors

Dr. Duque has received numerous accolades, including Fellowships from the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Hong Kong Academy of Medicine. His research excellence has been recognized with prestigious grants and scholarships. Additionally, he serves in honorary academic roles at leading medical institutions in China and Hong Kong. His contributions to paediatric immunology and allergy are widely acclaimed. 🥇🌟

🔎 Research Focus

Dr. Duque’s research focuses on paediatric allergy, immunology, and infectious diseases. He investigates food allergies, anaphylaxis, and immune responses in paediatric patients. His work includes studies on drug allergies in Chinese children, neuropsychiatric syndrome, and immune risk factors. Through multidisciplinary research, he aims to advance treatment strategies and improve paediatric healthcare outcomes. His collaborations with global medical centers further enhance his impactful research. 🧬🔬

 

Publication Top Notes

  • 🧒 Outcomes of pediatric patients with suspected allergies to COVID-19 vaccines (2025)

  • 🧒 Development and validation of the Post-COVID Symptom Scale for Children/Youth (PCSS-C/Y) (2024)

  • 🧒 Seroepidemiology of Measles and Rubella Among Hong Kong Young Adults and the Humoral Responses of a Measles-Mumps-Rubella Booster (2024

  • 🧬 Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients (2024)

  • 🐟 Combined Integrative RNA-Seq and Serological sIgE Analysis Enhances Understanding of Fish Allergen Profiles (2024)

  • 🐟 Fish Allergenicity Ladder and Parvalbumin Epitopes for Predicting Clinical Cross-reactivity and Reintroduction (2024)

  • 🦠 PD1+CD4+ T cells promote receptor editing and suppress autoreactivity of CD19+CD21low B cells (2024)

  • 💉 Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less than 3 years old during Omicron wave in Hong Kong (2024)

  • 🐟 Real-World Sensitization and Tolerance Pattern to Seafood in Fish-Allergic Individuals (2024)

  • 🧬 Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond (2024)

 

Ammu Kutty Radhakrishnan | Cancer Immunology | Best Researcher Award

Published on by Academic Awards

Prof. Ammu Kutty Radhakrishnan | Cancer Immunology | Best Researcher Award

Prof. Ammu Kutty Radhakrishnan, Monash University Malaysia, Malaysia

 

Prof. Ammu Kutty Radhakrishnan is a distinguished immunologist with a PhD from the University of Cambridge (1994), an MSc in Biochemistry (1990), and a BSc (First Class Honours) from the University of Malaya (1987). Currently, a Professor of Immunology at Monash University Malaysia, she has over 25 years of academic leadership and research experience. Prof. Ammu specializes in immunotherapy and food as medicine research, serving as Head of this research strength. Her career spans significant roles at International Medical University and Oxford. She is a research consultant, active in COVID-19 vaccine efforts, and supervises PhD and MSc students. 🌿🧬📚

 

Publication Profile

Google Scholar

Academic Excellence

Prof. Ammu Kutty Radhakrishnan has an exceptional academic background, with a PhD in Immunology from the University of Cambridge (1994) and degrees in Biochemistry from the University of Malaya. Her education forms a solid foundation for her expertise in immunology and biomedical sciences, contributing to her distinguished career.

Professional Experience

Prof. Radhakrishnan has held key roles, such as Professor at Monash University Malaysia and the International Medical University (IMU). Her leadership in academic programs, such as head of the Food as Medicine Research Strength and chief examiner roles, showcases her commitment to advancing education and research.

Research Contributions

Prof. Radhakrishnan has supervised numerous PhD and Master’s students, guiding 39 doctoral and 20 master’s research projects to completion. Her extensive research supervision experience highlights her dedication to fostering scientific inquiry and innovation. Additionally, her collaborative efforts with industry partners demonstrate her ability to apply research to real-world problems.

Conclusion

Prof. Ammu Kutty Radhakrishnan’s outstanding academic credentials, extensive research supervision, leadership roles, and global health contributions, she is an ideal candidate for the Best Researcher Award. Her work in immunology, biomedicine, and collaboration with industry partners demonstrates her excellence in both academic and applied research, making her a worthy contender for this prestigious recognition.

 

Publication Top Notes  

  • Protective effect of aqueous extract from Spirulina platensis against cell death induced by free radicals (2010) – 292 citations 🧪
  • Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59 (1994) – 259 citations 🧬
  • Rind of the rambutan, Nephelium lappaceum, a potential source of natural antioxidants (2008) – 193 citations 🍇
  • Current concepts of neurodegenerative mechanisms in Alzheimer’s disease (2018) – 176 citations 🧠
  • Bioactive Compounds: Natural Defense Against Cancer? (2019) – 169 citations 🌿
  • Protective mechanisms of flavonoids in Parkinson’s disease (2015) – 162 citations 🧑‍⚕️
  • Tocotrienol research: past into present (2012) – 157 citations 🌰
  • Standardised Mangifera indica extract is an ideal antioxidant (2009) – 149 citations 🥭
  • Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson’s disease (2020) – 128 citations 🚀
  • Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice (2004) – 126 citations 🧫
  • Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity (2013) – 124 citations 🧪

 

Maxwell Hubert Antwi | Immunology | Best Researcher Award

Published on by Academic Awards

Mr. Maxwell Hubert Antwi | Immunology | Best Researcher Award

Mr. Maxwell Hubert Antwi, Koforidua Technical University, Ghana

Dr. Maxwell Hubert Antwi is a dedicated researcher and educator in the field of Medical Laboratory Science. He holds a PhD and serves as an Assistant Lecturer at Koforidua Technical University, Ghana. His research interests encompass immunology, proteomics, global health, and infectious diseases like malaria. Dr. Antwi has authored several impactful publications, contributing significantly to the scientific community’s understanding of various health issues. Beyond academia, he actively engages in community service and professional development activities. With proficiency in Microsoft Office and Python programming, Dr. Antwi is also known for his leadership qualities and fluency in English and French. 🌍🔬

Publication Profile:

Orcid

Google Scholar

 

Education:

Maxwell Hubert Antwi pursued his academic journey with fervor, obtaining an MSc in Medical Laboratory Science from Kwame Nkrumah University of Science and Technology, Ghana, in 2018. His research delved into the intricate relationship between Vitamin D deficiency and cytokines (IL 10, TNF-alpha, IFN-gamma), under the guidance of esteemed Professor Samuel Asamoah Sakyi. Prior to this, he earned a BSc in Medical Laboratory Science from the University of Ghana in 2012. His undergraduate thesis, supervised by Professor E.K Wiredu, focused on the prevalence of unsatisfactory Pap smear reports and the potential association with cancer cell presence. 🎓

Certificate:

Maxwell Hubert Antwi expanded his expertise through a certificate program in Civil Society Management, a collaborative effort by the Young African Leadership Initiative (YALI-West Africa) and the Ghana Institute of Management and Public Administration (GIMPA). 🌍 Focusing on environmental sustainability, his research under the guidance of the Regional Leadership Center-West Africa (YALI-GIMPA) centered on single-use plastic waste management. This initiative showcased his commitment to addressing pressing global challenges and his dedication to making a positive impact on society. 🌱 Through this program, he honed his leadership skills and gained valuable insights into fostering community-driven solutions for a cleaner, healthier planet.

Awards and Honors:

Maxwell Hubert Antwi’s exceptional achievements have been recognized through prestigious honors and awards. In 2023, he received the Presidential Honour for Distinguished Service Award for his remarkable contributions during the COVID-19 pandemic, bestowed by the President of the Republic of Ghana at the Jubilee House. 🏅 Additionally, his leadership prowess was evident in 2019 when he was part of the winning team, earning the Young African Leadership Initiative (YALI) Pitching Award during Cohort 14 Training at the Regional Leadership Center-West Africa-Accra. 🌟 Antwi’s academic excellence was evident early on, as he was named the Best graduating student at The Comforter Junior High School in Kumasi, Ghana, in 2003. 🎓

 

Teaching Experience :

Maxwell Hubert Antwi has demonstrated a strong commitment to education through his extensive teaching experience in the medical field. 📚 Joining Koforidua Technical University’s Medical Laboratory Science Department in 2021 as an Assistant Lecturer, he imparted knowledge to undergraduate students in various courses, including Haematology, Medical Immunology, and Health and Safety. His dedication continued in previous years, where he engaged students at different levels of their academic journey, fostering learning environments conducive to growth and development. Antwi’s teaching expertise also extended beyond the university setting, as he contributed to the education of nursing students at Navrongo Community Nursing College. 🎓 His hands-on approach and commitment to student success exemplify his passion for teaching and mentorship.

 

Research Focus:

Maxwell Hubert Antwi’s research primarily focuses on public health, with a particular emphasis on infectious diseases and epidemiology. 🦠 His studies encompass a wide range of topics, including the prevalence and determinants of various health conditions such as Vitamin D deficiency, cancer burden attributable to risk factors, and the impact of infectious diseases like malaria and COVID-19. 🩺 Antwi’s work contributes significantly to understanding disease patterns, risk factors, and potential interventions, thereby aiding in the development of strategies for disease prevention and management. 🌍 Through his research endeavors, he strives to make meaningful contributions to global health and well-being.

Publication Top Notes:

  1. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …. 🩺 Cited by: 873, Year: 2022
  2. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 🌍 Cited by: 339, Year: 2022
  3. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 🔬 Cited by: 20, Year: 2023
  4. Non-life-threatening adverse reactions from COVID-19 vaccine; a cross-sectional study with self-reported symptoms among Ghanaian healthcare workers 💉 Cited by: 16, Year: 2021
  5. Prevalence and determinants of low testosterone levels in men with type 2 diabetes mellitus; a case-control study in a district hospital in Ghana 📉 Cited by: 10, Year: 2021
  6. A comparative analysis of the knowledge and stigmatizing attitude of Ghanaians and Nigerians towards COVID-19 survivors 🤝 Cited by: 7, Year: 2021
  7. Vitamin D deficiency is common in Ghana despite abundance of sunlight: A multicentre comparative cross-sectional study ☀️ Cited by: 6, Year: 2021
  8. Prevalence of Unsatisfactory Pap Smear and Associated Clinical History and Diagnosis in a Tertiary Teaching Hospital in Ghana 🩺 Cited by: 2, Year: 2019
  9. Assessment of platelet numbers and prevalence of thrombocytopenia among children with severe malaria at a tertiary teaching hospital🦟 Cited by: 1, Year: 2021
  10. Chemokine Receptors Expression on Peripheral CD4-Lymphocytes in Rheumatoid Arthritis: CD4+ CD183+ As A Diagnostics Marker for Disease Activity in Rheumatoid Arthritis 🔄 Year: 2024